CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | ZDRAVESKI ZORAN | Grant or award | +300,000 | 304,716 | ||
| 2026-01-20 | ZDRAVESKI ZORAN | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2025-01-03 | ZDRAVESKI ZORAN | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion | +54,895 | $4.85 | $266K | 67,111 |
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion | +25,000 | $3.27 | $82K | 92,111 |
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion | +13,125 | $1.81 | $24K | 105,236 |
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion | +64,166 | $2.49 | $160K | 169,402 |
| 2024-08-23 | ZDRAVESKI ZORAN | Sale | −164,686 | $5.78 | $952K | 4,716 |
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion · Stock Option (Right to Buy) | −54,895 | 30,105 | ||
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 25,000 | ||
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion · Stock Option (Right to Buy) | −13,125 | 21,875 | ||
| 2024-08-23 | ZDRAVESKI ZORAN | Exercise or conversion · Stock Option (Right to Buy) | −64,166 | 365,834 | ||
| 2024-01-12 | ZDRAVESKI ZORAN | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | ||
| 2023-06-13 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +430,000 | 430,000 | ||
| 2023-02-02 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2022-07-25 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-01-18 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2021-09-23 | ZDRAVESKI ZORAN Chief Legal Officer | Purchase | +4,716 | $7.48 | $35K | 4,716 |
| 2021-09-07 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 |
Page 1 of 1 · 19 trades